Outcomes of subretinal macular hemorrhage treatment: a 7-year retrospective cohort study at Oslo University Hospital

Abstract Purpose Subretinal macular hemorrhage (SRMH) is a vision-threatening condition with no consensus on optimal treatment. This study evaluated the outcomes of five treatment modalities and their correlation with patient characteristics and optical coherence tomography findings. Methods A retro...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Krystian Andrzej Dziedzic, Filippo Confalonieri, Beáta Éva Petrovski, Lyubomyr Lytvynchuk, Ragnheidur Bragadottir, Ivan Borjan, Xhevat Lumi, Goran Petrovski
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-11-01
coleção:	International Journal of Retina and Vitreous
Assuntos:	Subretinal macular hemorrhage (SRMH) Anti-VEGF therapy Tissue plasminogen activator (tPA) Pars plana vitrectomy (PPV) Best corrected visual acuity (BCVA) tPA and gas displacement
Acesso em linha:	https://doi.org/10.1186/s40942-025-00749-3
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!